FDA Inspection 1199304 - Reveragen Biopharma Inc. - March 06, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Reveragen Biopharma Inc., with an inspection on March 6, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Reveragen Biopharma Inc.
Inspection Date: March 6, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 7b9c6294-f474-42d7-8a48-9f7b86f9126d

Violation Codes2

21 CFR 312.53(b)21 CFR 312.56(b)

Full citation text and observation details available on the Dashboard.